Ipsen and Marengo Therapeutics Announce Strategic Partnership to Advance Two Precision Immuno-Oncology Candidates
In order to advance two of Marengo’s preclinical STAR platform-generated candidates into the clinic, Ipsen and Marengo Therapeutics, Inc. today established a collaborative agreement. The partnership will take advantage of Ipsen’s global oncology footprint and Marengo’s in-house R&D experience to…